ESSA Pharma Inc.: cashflow_financing
| Value | {"amount": -4045582, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"} |
|---|---|
| Period | 2019-10-01 – 2020-03-31 |
| Status | current |
| Entity | ESSA Pharma Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T16:47:45.295254+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/d1eb9778-6b3a-47f6-b4f3-a246a5e7c1d5
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001558370-21-006061 · Open the official SEC filing →Retrieved: 2026-08-19T16:47:45.295254+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001633932/cashflow-financing/2020-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/d1eb9778-6b3a-47f6-b4f3-a246a5e7c1d5
History
- no predecessors — first report